ClinicalTrials.gg
RecruitingNCT06365151Updated Sep 4, 2025

An Algorithm for Approaching Temporomandibular Disorders With Osteopathic Manual Therapy in Patients With Fibromyalgia

An interventional study of Osteopathic manual therapy and Sham osteopathic manual therapy in Fibromyalgia and Temporomandibular Disorder, sponsored by Universitat de Lleida. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-04.

Sponsored by Universitat de Lleida · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Apr 2024; still recruiting 2 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
114
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 151 studies in Fibromyalgia with a site in Spain — 16 open to participants now, 21 under way, none of them phase 3. Fibromyalgia · Spain.

Planned enrollment
33rd of 135
114 · median 66
Started
2024
with 10 others
No phase
113 of 151
14 open now
Primary completion
2025-07
later than 7 of 20 live
Registered
128th of 151
by date

Among the 151 studies in Fibromyalgia with a site in Spain, this one is the 33rd largest by planned enrollment of the 135 interventional ones that give a count, is one of 11 that started in 2024, is one of 113 with no phase, reaches primary completion later than 7 of the 20 other live ones, and was the 128th registered.

Fibromyalgia

1,245 studies on the registry are indexed under Fibromyalgia; 256 are open to participants now.

Browse Fibromyalgia studies →

Open to participants now

16 of the 151 studies in Fibromyalgia with a site in Spain are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 161 Fibromyalgia studies recruiting now, 51 (32%) set no upper age limit and 96 (60%) stop at 75 or younger; 15 take children under 18; 35 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 151 studies in Fibromyalgia with a site in Spain, or all of them as a file.
02

Study summary

Nowadays, fibromyalgia is the rheumatic disorder with the highest levels of deterioration in quality of life. Among the comorbidities it presents, one of the most frequent is temporomandibular disorders. A randomized clinical study will be conducted to evaluate the effectiveness of an osteopathic manual therapy approach algorithm in a group of patients with fibromyalgia and temporomandibular disorders.

03

Conditions studied

  • Fibromyalgia
  • Temporomandibular Disorder

Keywords

  • temporomandibular joint disorders
  • fibromyalgia
  • Osteopathic medicine
  • chronic pain
  • musculoskeletal manipulations
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • be diagnosed as suffering from fibromyalgia,
  • present moderate pain or dysfunction of more than 3 months' duration in the temporomandibular joint,
  • be over 18 years old,
  • understand Spanish and/or Catalan correctly,
  • and read and accept the form

Exclusion criteria

Exclusion Criteria:

  • history of trauma or recent surgery to the head, face or neck;
  • systemic, rheumatic or central nervous system diseases;
  • diagnosis of malignant tumors or cancer in the orofacial region;
  • participate in other studies at the same time.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
114 participants (estimated)

Study arms

  • Experimental
    experimental

    treatment will be carried out following a previously validated approach algorithm. Articulatory techniques, soft tissue mobilization techniques, trigger point inhibition, etc. will be used.

    Other: Osteopathic manual therapy

  • Sham comparator
    sham

    A sham treatment will be performed following a previously validated approach algorithm. techniques will be simulated in such a way that they will have no therapeutic effect.

    Other: Sham osteopathic manual therapy

Interventions

  • OtherOsteopathic manual therapy

    osteopathic manual treatment aimed at improving the function and pain of the temporomandibular joint.

  • OtherSham osteopathic manual therapy

    a sham osteopathic manual treatment without therapeutic effect

06

What researchers measure

Primary outcomes

  1. catastrophizing

    The Pain Catastrophizing scale (PCS), evaluates the degree og catastrophic thinking gdue to pain.It is a 13-item scale, with a total range from 0 to 52. Higher scores are associated with a greater degree of pain catastrophizing.

    Time frame: From enrollment to the end of treatment at 6 weeks

  2. functional limitation

    evaluated with tue short version of the Jaw functional limitation scale (JFLS-8). Evaluates the functional status of the masticatory system. Questionnaire with 8 items, each with a scale from 0 to 10. A higher score suggests a greater limitation.

    Time frame: From enrollment to the end of treatment at 6 weeks

  3. functional status, disability and pain

    collected in the craniofacial pain and disability inventory (CFPDI). Self administered questionnaire of 21 items. Each item is scored on a Likert scale from 0 to 3.

    Time frame: From enrollment to the end of treatment at 6 weeks

  4. pain and tinnitus

    evaluated with a visual analog scale (VAS). Scale from 0 to 10, where 0 indicates no pain and 10 the worst pain imaginable.

    Time frame: From enrollment to the end of treatment at 6 weeks

  5. myofascial trigger points

    presence of a palpable tight band, presence of a hyperirritable tenderpoint within te tight band, local twitch response elicited by acute palpation of the tight band, and presence refered pain in response ot trigger point compression.

    Time frame: From enrollment to 4 weeks

  6. Range of motion

    measurements taken with a ruler: maximum opening, maximun active opening without pain and lateralization.

    Time frame: From enrollment to 4 weeks

07

Study locations

1 of 1 sites recruiting
  • Osteopatia i Fisioteràpia Cornellà
    Cornellà de Llobregat, Barcelona 08940, Spain
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2024 to primary completion in Jul 2025, 15 months.

Of 439 non-industry interventional studies with no phase under Fibromyalgia, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's 15 months is close to that.

Counting every sponsor, half of 452 studies reached it within 15 months; a quarter within 6 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 8, 2024
First posted
Apr 15, 2024
StartActual
Apr 5, 2024
Primary completionActual
Jul 31, 2025
CompletionEst.
Apr 5, 2026
Last update
Sep 4, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06365151
Lead sponsor
Universitat de Lleida
Responsible party
Llanos de la Iglesia (Principal investigator, Universitat de Lleida) — Principal investigator
First posted
Apr 15, 2024
Start date
Apr 5, 2024
Primary completion
Jul 31, 2025
Completion
Apr 5, 2026 (estimated)
Last update
Sep 4, 2025

Study contacts

Llanos de la Iglesia, MsC
Contact
llanos.delaiglesia@gmail.com
+4679536992
Llanos de la Iglesia
Contact
llanos.delaiglesia@gmail.com
+34679536992
Llanos de la Iglesia
principal investigator · Departament de infermeria i fisioterapia. universitat de Lleida

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion